가정용 진단 시장 : 전략과 동향 - 용도별, 채널별, 기술별, 국가별 예측 - 이그제큐티브 컨설턴트 가이드와 인공지능의 영향(2025-2029년)

Home Diagnostics Markets Strategies and Trends. Forecasts by Application by Channel by Technology and by Country. With Market Analysis and Executive Guides. Including Impact of Artificial Intelligence. 2025 to 2029

US $ 6,995 ￦ 10,388,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495 ￦ 15,587,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 20,785,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 개요

새로운 기술은 검사의 방법과 장소의 이미지를 바꾸어 놓았습니다. 진단 검사는 바로 가정으로 옮겨가고 있습니다. COVID-19 팬데믹은 이러한 중요한 변화의 시작에 불과합니다. 이 보고서에서는 모든 가정용 진단 약품에 대한 전망을 살펴봅니다. 어디서 무슨 일이 일어나고 있는지, 그리고 어떤 업체들이 진입하고 있는지 알아볼 수 있습니다.

흥미진진한 기술 개발, 특히 서로 다른 분석 기술 간의 시소는 역동적으로 성장하고 진화하는 세계 시장을 예고합니다. 또한 새로운 기술도 시야에 들어오고 있습니다.

이 보고서는 400페이지 가까운 정보량으로 구성되어 있습니다.

이 보고서에는 15 국가와 4 지역별로 상세하게 분석되어 있습니다. 이 보고서 구매자는 전 세계 모든 국가별 상세 내역을 확인할 수 있습니다.

최신 데이터를 통해 자신 있게 투자 판단과 밸류에이션을 할 수 있습니다.

세계의 가정용 진단 시장에 대해 조사했으며, 시장의 개요와 용도별, 채널별, 기술별, 국가별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 시장 가이드

제2장 서론과 시장의 정의

• 가정용 진단이란 무엇인가?
• 재택 검사 - 진단에서의 조용한 혁명
• 셀프 대 센드 대 사내 - 누가 알고 있었는가?
• 시장 정의
• 용도 부문
• 조사 방법
• 시점 : 헬스케어와 IVD 업계

제3장 업계 개요

• 시장 참여 조직
  • 학술연구기관
  • 진단 시험 개발자
  • 계측 기기 공급업체
  • 약품·시약 제조업체
  • 병리 공급업체
  • 독립계 임상 검사실
  • 공공 국립/지역 연구소
  • 병원 검사실
  • 임상 검사실
  • 감사 기관
  • 인증 기관
• 진단 시장 부문
• 업계 구조

제4장 시장 동향

• 성장 촉진요인
• 성장 억제요인
• 진단 기술개발

제5장 가정용 진단의 최근 동향

제6장 주요 가정용 진단 기업의 개요

• 1DropDiagnostics
• 23andME Inc.
• Abbott Laboratories
• Accel Diagnostics
• ADT Biotech
• Akonni Biosystems
• AlphaBiolabs
• Alveo Technologies
• Anitoa
• Applied BioCode
• Atomo Diagnostics
• Aureum Diagnostics
• Aus Diagnostics
• Becton, Dickinson and Company
• Binx Health
• Biocartis
• BioFire Diagnostics(bioMerieux)
• bioMerieux Diagnostics
• Bio-Rad Laboratories, Inc
• Bosch Healthcare Solutions GmbH
• Cepheid(Danaher)
• Cue Health
• Curetis(OpGen)
• DBS Systems
• Detect
• Diagenode Diagnostics(Hologic)
• Diasorin S.p.A.
• Domus Diagnostics
• Ellume
• Everywell
• Genomadix
• Getlabs
• Grip Molecular Technologies
• Healthy.io
• Hologic
• Inflammatix
• Invetech
• Iollo
• J&J Innovative Medicine
• Karius
• Laboratory Corporation of America
• Letsgetchecked
• LightDeck Diagnostics
• Lucira Health(Pfizer)
• LumiraDx
• Meep
• MFB Fertility
• myLabBox
• NanoDx
• Nanomix
• OraSure Technologies
• Oxford Nanopore Technologies
• Panagene
• Prenetics
• Primerdesign(Novacyt)
• Prominex
• Proof Diagnostics
• Qiagen
• QuantuMDx
• Quest Diagnostics
• QuidelOrtho
• Randox Toxicology
• Roche Diagnostics
• Salignostics
• SD Biosensor
• Seegene
• Siemens Healthineers
• T2 Biosystems
• TestCard
• Thermo Fisher Scientific
• Thriva
• Visby Medical
• XCR Diagnostics
• YourBio Health

제7장 세계 시장 규모

• 세계의 가정용 진단 시장 규모(국가별)
• 세계의 가정용 진단 시장 규모(용도별)
• 세계의 가정용 진단 시장 규모(채널별)
• 세계의 가정용 진단 시장 규모(기술별)

제8장 용도별 세계 시장

• 호흡기
• STD
• UTI
• 임신
• 배란
• DNA
• 기타

제9장 채널별 세계 시장

• 점포
• 온라인
• 기타

제10장 기술별 세계 시장

• 면역측정
• 화학
• 핵산
• 기타

제11장 부록

KSA

영문 목차

영문목차

Report Overview:

New technology has changed the picture on how and where testing is done. Diagnostic testing is moving right into the home. The pandemic was just the start of this important trend. This report explores the outlook for all manner of At Home Diagnostics. Find out where the action is and the learn about the players.

Exciting technical developments especially in the seesaw between different analytic technology, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even newer technology is on the horizon.

The report has nearly 400 pages of information.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

• 1.1. Situation Analysis
• 1.2. Guide for Executives and Marketing Staff
• 1.3. Guide for Investment Analysts and Management Consultants
• 1.4. Impact of Aritificial Intelligence

2. Introduction and Market Definition

• 2.1. What are Home Diagnostics?
• 2.2. Home Testing - the quiet revolution in diagnostics
• 2.3. Self vs. Send vs. In House - Who knew?
  • 2.3.1. Self
  • 2.3.2. Send
  • 2.3.3. In-House
• 2.4. Market Definition
  • 2.4.1. Retail vs. Wholesale
• 2.5. Application Segments
  • 2.5.1. Channel Segments
  • 2.5.2. Technology Segments
  • 2.5.3. Currency
  • 2.5.4. Years
• 2.6. Methodology
  • 2.6.1. Methodology
  • 2.6.2. Sources
  • 2.6.3. Authors
• 2.7. Perspective: Healthcare and the IVD Industry
  • 2.7.1. Global Healthcare Spending
  • 2.7.2. Spending on Diagnostics
  • 2.7.3. Important Role of Insurance for Diagnostics

3. Industry Overview

• 3.1. Players in a Dynamic Market
  • 3.1.1. Academic Research Lab
  • 3.1.2. Diagnostic Test Developer
  • 3.1.3. Instrumentation Supplier
  • 3.1.4. Chemical/Reagent Supplier
  • 3.1.5. Pathology Supplier
  • 3.1.6. Independent Clinical Laboratory
  • 3.1.7. Public National/regional Laboratory
  • 3.1.8. Hospital Laboratory
  • 3.1.9. Physicians Office Lab (POLS)
  • 3.1.10. Audit Body
  • 3.1.11. Certification Body
• 3.2. Diagnostic Market Segments
  • 3.2.1. Traditional Market Segmentation
  • 3.2.2. Laboratory Focus and Segmentation
  • 3.2.3. Segmenting the Home Diagnostics Market
• 3.3. Industry Structure
  • 3.3.1. Hospital Testing Share
  • 3.3.2. Economies of Scale
  • 3.3.3. Hospital vs. Central Lab
  • 3.3.4. Physician Office Lab's
    • 3.3.4.1. The Problem with POLS
  • 3.3.5. Physician's and Home Diagnostics
  • 3.3.6. Pharmacies and Home Diagnostics
    • 3.3.6.1. The Diagnostic Plight of Pharmacies - Trying to do good
    • 3.3.6.2. The Theranos Legacy

4. Market Trends

• 4.1. Factors Driving Growth
  • 4.1.1. Privacy and Anonymity
  • 4.1.2. The Internet Effect
  • 4.1.3. Rapid Result
  • 4.1.4. The Wellness Movement
  • 4.1.5. The COVID-19 Impact
• 4.2. Factors Limiting Growth
  • 4.2.1. Trust Factor
  • 4.2.2. Infectious Disease is Declining But...
  • 4.2.3. Wellness Hurts
  • 4.2.4. Economic Growth improves Living Standards
• 4.3. Diagnostic Technology Development
  • 4.3.1. The Multiplex Paradigm Shift
  • 4.3.2. NAT vs. Lateral Flow
  • 4.3.3. The Unusual Role of GPS
  • 4.3.4. Self and Send Competition
  • 4.3.5. The Relationship to DTC Genetic
  • 4.3.6. The Relationship to TeleHealth
  • 4.3.7. Sample Collection - Who Knew?

5. Home Diagnostics Recent Developments

• 5.1. Recent Developments - Importance and How to Use This Section
  • 5.1.1. Importance of These Developments
  • 5.1.2. How to Use This Section
• 5.2. Health Canada Approves NanoSpeed Diagnostics POC Vitamin D Test
• 5.3. Visby Medical At-Home MDx STI Test Approved
• 5.4. Cubit Diagnostics Gets Funding for COVID/Flu Test on Multimodal Platform
• 5.5. OraSure Technologies Acquires Sherlock Biosciences
• 5.6. Atomo Diagnostics Awarded Grant for Syphilis Test
• 5.7. Shuwen Biotech Gets Approval for POC Preeclampsia Test
• 5.8. Watmind Get Two EUAs
• 5.9. Capitainer, Life Genomics Partner on Self-Sampling Diagnostics
• 5.10. MyGeneticScreen Home Test Launched
• 5.11. Demand for OTC Self-Tests Tempered by Lack of Reimbursement
• 5.12. DiaCarta OTC Fecal Occult Blood Test Receives FDA Approval
• 5.13. LetsGetChecked Nabs FDA Authorization for Chlamydia, Gonorrhea Test
• 5.14. DiagMetrics Developing Breath Assays
• 5.15. Co-Diagnostics Awarded $2.3M for TB, HPV Tests
• 5.16. POC Developers Nuclein and Minute Molecular Dx Merge
• 5.17. ReadyGo Dx to Make MDx Testing a 'Snap'
• 5.18. Altratech Enters POC Testing Space by Supplanting PCR
• 5.19. Sherlock Biosciences to Acquire Sense Biodetection
• 5.20. Scripps Research, Cue Health to Offer Home Based Test-to-Treat Program
• 5.21. KSL Pulse Scientific to Distribute Home Molecular Test in Canada
• 5.22. Juno Diagnostics Offers NIPT With At-Home Sample Collection
• 5.23. Sherlock Biosciences Adds to Diagnostic Toolkit
• 5.24. Morgan Health Invests in LetsGetChecked
• 5.25. Prenetics ColoClear by Circle
• 5.26. Detect to Roll Out Next-Gen Molecular Instrument
• 5.27. Diagnostics for the Real World Third-Generation POC Platform
• 5.28. Labcorp Partnering With Getlabs for Home Collection
• 5.29. Salignostics Closes Funding Round
• 5.30. Cue Health Targets DTC Market in 2022
• 5.31. Grip Molecular Developing Home Respiratory Panel
• 5.32. Mainz Biomed Developing Home ColoAlert Assay
• 5.33. MFB Fertility Closes Series A Financing Round
• 5.34. Continued Demand for SARS-CoV-2 Rapid Tests
• 5.35. Rapid Covid-19 Test Results Risk Going Uncounted
• 5.36. FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
• 5.37. Researchers Develop 15-Minute PCR System
• 5.38. Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
• 5.39. Lucira Health Files for $115M IPO
• 5.40. Spectrum Solutions Gets CE Mark for Saliva Collection Devices

6. Profiles of Key Home Diagnostics Companies

• 6.1. 1DropDiagnostics
• 6.2. 23andME Inc.
• 6.3. Abbott Laboratories
• 6.4. Accel Diagnostics
• 6.5. ADT Biotech
• 6.6. Akonni Biosystems
• 6.7. AlphaBiolabs
• 6.8. Alveo Technologies
• 6.9. Anitoa
• 6.10. Applied BioCode
• 6.11. Atomo Diagnostics
• 6.12. Aureum Diagnostics
• 6.13. Aus Diagnostics
• 6.14. Becton, Dickinson and Company
• 6.15. Binx Health
• 6.16. Biocartis
• 6.17. BioFire Diagnostics (bioMerieux)
• 6.18. bioMerieux Diagnostics
• 6.19. Bio-Rad Laboratories, Inc
• 6.20. Bosch Healthcare Solutions GmbH
• 6.21. Cepheid (Danaher)
• 6.22. Cue Health
• 6.23. Curetis (OpGen)
• 6.24. DBS Systems
• 6.25. Detect
• 6.26. Diagenode Diagnostics (Hologic)
• 6.27. Diasorin S.p.A.
• 6.28. Domus Diagnostics
• 6.29. Ellume
• 6.30. Everywell
• 6.31. Genomadix
• 6.32. Getlabs
• 6.33. Grip Molecular Technologies
• 6.34. Healthy.io
• 6.35. Hologic
• 6.36. Inflammatix
• 6.37. Invetech
• 6.38. Iollo
• 6.39. J&J Innovative Medicine
• 6.40. Karius
• 6.41. Laboratory Corporation of America
• 6.42. Letsgetchecked
• 6.43. LightDeck Diagnostics
• 6.44. Lucira Health (Pfizer)
• 6.45. LumiraDx
• 6.46. Meep
• 6.47. MFB Fertility
• 6.48. myLabBox
• 6.49. NanoDx
• 6.50. Nanomix
• 6.51. OraSure Technologies
• 6.52. Oxford Nanopore Technologies
• 6.53. Panagene
• 6.54. Prenetics
• 6.55. Primerdesign (Novacyt)
• 6.56. Prominex
• 6.57. Proof Diagnostics
• 6.58. Qiagen
• 6.59. QuantuMDx
• 6.60. Quest Diagnostics
• 6.61. QuidelOrtho
• 6.62. Randox Toxicology
• 6.63. Roche Diagnostics
• 6.64. Salignostics
• 6.65. SD Biosensor
• 6.66. Seegene
• 6.67. Siemens Healthineers
• 6.68. T2 Biosystems
• 6.69. TestCard
• 6.70. Thermo Fisher Scientific
• 6.71. Thriva
• 6.72. Visby Medical
• 6.73. XCR Diagnostics
• 6.74. YourBio Health

7. Global Market Size

• 7.1. Home Diagnostics Global Market Size by Country
  • 7.1.1. Home Diagnostics Global Market Size by Country Table
  • 7.1.2. Home Diagnostics Global Market Size by Country Chart
• 7.2. Home Diagnostics Global Market Size by Application
  • 7.2.1. Home Diagnostics Global Market Size by Application Table
  • 7.2.2. Home Diagnostics Global Market Size by Application Share by Year
  • 7.2.3. Home Diagnostics Global Market Size by Application Base vs Final
  • 7.2.4. Home Diagnostics Global Market Size by Application Base Year
  • 7.2.5. Home Diagnostics Global Market Size by Application Final Year
  • 7.2.6. Home Diagnostics Global Market Size by Application Segment Growth
• 7.3. Home Diagnostics Global Market Size by Channel
  • 7.3.1. Home Diagnostics Global Market Size by Channel Table
  • 7.3.2. Home Diagnostics Global Market Size by Channel Share by Year
  • 7.3.3. Home Diagnostics Global Market Size by Channel Base vs Final
  • 7.3.4. Home Diagnostics Global Market Size by Channel Base Year
  • 7.3.5. Home Diagnostics Global Market Size by Channel Final Year
  • 7.3.6. Home Diagnostics Global Market Size by Channel Segment Growth
• 7.4. Home Diagnostics Global Market Size by Technology
  • 7.4.1. Home Diagnostics Global Market Size by Technology Table
  • 7.4.2. Home Diagnostics Global Market Size by Technology Share by Year
  • 7.4.3. Home Diagnostics Global Market Size by Technology Base vs Final
  • 7.4.4. Home Diagnostics Global Market Size by Technology Base Year
  • 7.4.5. Home Diagnostics Global Market Size by Technology Final Year
  • 7.4.6. Home Diagnostics Global Market Size by Technology Segment Growth

8. Global Market by Application

• 8.1. Respiratory Market
  • 8.1.1. Respiratory Market by Country Table
  • 8.1.2. Respiratory Market Chart
• 8.2. STD Market
  • 8.2.1. STD Market by Country Table
  • 8.2.2. STD Market Chart
• 8.3. UTI Market
  • 8.3.1. UTI Market by Country Table
  • 8.3.2. UTI Market Chart
• 8.4. Pregnancy Market
  • 8.4.1. Pregnancy Market by Country Table
  • 8.4.2. Pregnancy Market by Chart
• 8.5. Ovulation Market
  • 8.5.1. Ovulation Market by Country Table
  • 8.5.2. Ovulation Market by Chart
• 8.6. DNA Market
  • 8.6.1. DNA Market by Country Table
  • 8.6.2. DNA Market Chart
• 8.7. Other Market
  • 8.7.1. Other Market by Country Table
  • 8.7.2. Other Market Chart

9. Global Market by Channel

• 9.1. Store Market
  • 9.1.1. Store Market by Country Table
  • 9.1.2. Store Market Chart
• 9.2. Online Market
  • 9.2.1. Online Market by Country Table
  • 9.2.2. Online Market Chart
• 9.3. Other Channel Market
  • 9.3.1. Other Channel by Country Table
  • 9.3.2. Other Channel Market Chart

10. Global Market by Technology

• 10.1. Immunoassay Market
  • 10.1.1. Immunoassay Market by Country Table
  • 10.1.2. Immunoassay Market Chart
• 10.2. Chemistry Market
  • 10.2.1. Chemistry Market by Country Table
  • 10.2.2. Chemistry Market Chart
• 10.3. Nucleic Acid Market
  • 10.3.1. Nucleic Acid Market by Country Table
  • 10.3.2. Nucleic Acid Market Chart
• 10.4. Other Technology Market
  • 10.4.1. Other Technology Market by Country Table
  • 10.4.2. Other Technology Market Chart

11. Appendices

• 11.1. United States Medicare System: Clinical Laboratory Fees Schedule
• 11.2. The Most Used IVD Assays
• 11.3. The Highest Grossing Assays